1700001C19Rik Activators
1700001C19Rik Activators are a series of chemical compounds that, through various cellular mechanisms, indirectly stimulate the functional activity of 1700001C19Rik. Compounds such as Forskolin and IBMX elevate the intracellular levels of cAMP and cGMP, respectively, which can lead to the activation of PKA and other cAMP-dependent signaling pathways, potentially resulting in the phosphorylation of proteins that interact with 1700001C19Rik. Ionomycin and A23187, both calcium ionophores, increase the intracellular calcium concentration, asecond messenger crucial for the operation of numerous signaling cascades that could intersect with the pathways regulating 1700001C19Rik. The activation of PKC by PMA and the kinase inhibition by EGCG similarly disrupt cellular equilibrium, thereby potentially removing inhibitory controls or providing stimulatory signals that could augment the activity levels of 1700001C19Rik.
Moreover, the influence of lipid signaling by Sphingosine-1-phosphate suggests a role in the activation of receptors and downstream signaling that may implicate 1700001C19Rik. Inhibition of key enzymes in signal transduction pathways, as seen with LY294002, U0126, SB203580, and Genistein, can lead to a reconfiguration of cellular signaling networks, resulting in the enhancement of 1700001C19Rik activity. This reconfiguration could manifest as the release of 1700001C19Rik from negative feedback loops or the facilitation of pathways that contribute to its activation. Similarly, Thapsigargin's role in increasing cytosolic calcium levels may also engage calcium-dependent proteins and pathways that collaborate with or regulate 1700001C19Rik, leading to its functional enhancement. These chemicals, through their targeted biochemical actions, collectively facilitate the indirect activation of 1700001C19Rik, thereby enhancing the protein's functional roles in cellular processes without requiring upregulation at the transcriptional or translational level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentrations. This elevation can activate calcium-dependent proteins and signaling pathways that might interact with or regulate 1700001C19Rik, leading to its activation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which is involved in cell signal transduction. Upon activation, PKC may phosphorylate substrates that are part of the signaling cascade involving 1700001C19Rik, thus enhancing its activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, which degrade cAMP and cGMP. By inhibiting these enzymes, IBMX raises the levels of these cyclic nucleotides, which could activate pathways that enhance the functionality of 1700001C19Rik. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit certain types of kinases. The inhibition of these kinases may reduce negative regulatory mechanisms on pathways involving 1700001C19Rik, which could result in its enhanced activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore which increases intracellular calcium and can mimic the effect of calcium as a second messenger. This could enhance the activity of 1700001C19Rik if it is regulated by calcium signaling. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
This lipid signaling molecule can activate sphingosine-1-phosphate receptors and subsequent downstream signaling pathways that may include or activate 1700001C19Rik. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of PI3K, which can alter signaling pathways downstream of PI3K. This could potentially relieve negative feedback or competitive inhibition on pathways involving 1700001C19Rik, leading to its activation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 specifically inhibits p38 MAPK. By modulating this pathway, the compound could indirectly enhance the activity of 1700001C19Rik if the protein is involved in the p38 MAPK signaling cascade. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to an increase in cytosolic calcium levels. Elevated calcium may activate pathways or proteins that work synergistically with 1700001C19Rik, enhancing its activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that can disrupt certain signaling pathways. If 1700001C19Rik functions downstream of these pathways, its activity could be enhanced by the reduction of competitive signaling through tyrosine kinase inhibition. | ||||||